Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     Biotechnology     Life Sciences Research     Drug Discovery     In vitro drug discovery    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

Global High throughput screening Market Research Report

  • Report Code: HI 1000
  • Publish Date: Upcoming
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount

The global high-throughput screening market is mainly driven by target identification & validation, efficacy & safety screening, and monitoring of cell-based activity. The market was valued at $14.38 billion in 2013, and is expected to reach $20.58 billion by 2018, at a CAGR of 7.40% from 2013 to 2018. The high rate of utilization of high-throughput screening (HTS) technologies by pharmaceutical companies, for the screening of compound libraries, has led to the growth of this market.

 

The report analyzes the global high-throughput screening market, primarily categorized by technology, product, end-user, and application. The technology segment is further categorized into ultra-high-throughput screening (uHTS), cell-based assay, lab-on-a-chip, label-free technology, and bioinformatics. By product, the HTS market is segmented into instrument, consumable/reagent, and software & service. The end-user segment categorizes the high-throughput screening market into pharmaceutical, biotechnology, academia & government, and contract research organization. The application segment of the high-throughput screening comprises target identification, primary screening, toxicology, and stem cell biology.

 

The cell-based assay segment accounted for the largest share of 58% of the global high-throughput screening market in 2013, followed by the lab-on-a-chip segment. The cell-based assay segment was valued at $7.90 billion in 2013, and is expected to grow at a CAGR of 6.70%, to reach $11.03 billion by 2018. The label-free technology market is expected to grow at a CAGR of 11.10% from 2013 to 2018, to reach $1.60 billion by 2018. The lab-on-a-chip technology segment is also expected to grow at a CAGR of 8.00% from $1.90 billion in 2013.

 

The global high-throughput screening market is mainly driven by the adoption of open innovation models by pharmaceutical companies to increase the use of high-throughput screening, increasing drug discovery initiatives by academic and government institutions to boost the demand for high-throughput screening products, and increasing capital investments in high-throughput screening technology by major firms such as PerkinElmer (U.S.), Beckman Coulter (U.S.), and Tecan Group (Switzerland), among others. Private equity firms and venture capitalists are increasingly investing in the HTS market in countries, such as India, China, and Japan. The Asian region provides immense growth opportunities for the high-throughput screening market, as it accounts for more than half of the world’s total population.

 

The report also provides an extensive competitive landscaping of the leading companies operating in this market. The major players in the market include Agilent Technologies, Inc. (U.S.), PerkinElmer (U.S.), Beckman Coulter, Inc. (a subsidiary of Danaher Corporation) (U.S.), Sigma-Aldrich Corporation (U.S.), and Tecan Group (Switzerland), among others. Furthermore, segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.

 

Customization Options

Along with the market data, you can also customize the MMM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and deep-dive analysis of the following parameters:

 

Product Analysis

  • Usage pattern (in-depth trend analysis) of products (segment-wise)
  • Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment levels
  • End-user adoption rate analysis of the products (segment-wise and country-wise)
  • Comprehensive coverage of product approvals, pipeline products, and product recalls

 

Volume Data

  • Data related to end-user segments of the market, such as pharmaceutical, biotechnology, academia and government, and contract research organization

 

Researchers Perception Analysis

  • Fast turn-around analysis of researchers’ responses to market events and trends
  • Pattern analysis of usage of ultra-high-throughput screening (uHTS), cell-based assay, lab-on-a-chip, label-free technology, and bioinformatics by researchers
  • Researchers’ opinions about products from different companies

 

Brand/Product Perception Matrix

  • Comprehensive study of customers’ perception and behavior through our in-built social connect tool checking the vitality and tonality of blogs
  • An analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)

 

Pricing Trends

  • Cost analysis of ultra-high-throughput screening (uHTS), cell-based assay, lab-on-a-chip, label-free technology, and bioinformatics in major countries
  • Investments made in the global high-throughput screening market

 

Competitive Intelligence

  • Company share analysis of the top players in the global HTS market
  • Crucial developments and strategies that companies inculcate in their portfolios


1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Submarkets
4.1 Lab automation equipment

Please fill in the form below to receive a free copy of the Summary of this Report
















Global High throughput screening Market Research Report

* Enter the text from the image to the text box :

refresh captcha
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE PUBLISHED
North American High throughput screening North American High throughput screening
The North American High Throughput Screening market was valued at $6454.3 million in 2013 and is expected to reach $9046.8 million by 2018, growing at a CAGR of 7.0% from 2013 to 2018. High Throughput Screening market is primarily categorized by technology, product, end user, and application. By technology, the HTS market is categorized into ultra high throughput screening (uHTS), cell-based assays, lab-on-a-chip, label-free technology, and bioinformatics. By product, the HTS market is segmented into instruments, consumables/reagents, and software and services. By end user, the High Throughput Screening market is categorized into pharmaceutical, biotechnology, academia and government, contract research organizations, and others. By application, the High Throughput Screening market is classified into target identification, primary screening, toxicology, stem cell biology, and others. Major players in the market include Agilent Technologies, Inc. (U.S.), PerkinElmer (U.S.), Beckman Coulter, Inc. (a subsidiary of Danaher Corporation) (U.S.), Sigma-Aldrich Corporation (U.S.) and Tecan Group (Switzerland).
Upcoming
European High throughput screening European High throughput screening
The European High Throughput Screening market was valued at $3794.7 million in 2013 and is expected to reach $5194.3 million by 2018, growing at a CAGR of 6.5% from 2013 to 2018. High Throughput Screening market is primarily categorized by technology, product, end user, and application. By technology, the HTS market is categorized into ultra high throughput screening (uHTS), cell-based assays, lab-on-a-chip, label-free technology, and bioinformatics. By product, the HTS market is segmented into instruments, consumables/reagents, and software and services. By end user, the High Throughput Screening market is categorized into pharmaceutical, biotechnology, academia and government, contract research organizations, and others. By application, the High Throughput Screening market is classified into target identification, primary screening, toxicology, stem cell biology, and others. Major players in the market include Agilent Technologies, Inc. (U.S.), PerkinElmer (U.S.), Beckman Coulter, Inc. (a subsidiary of Danaher Corporation) (U.S.), Sigma-Aldrich Corporation (U.S.) and Tecan Group (Switzerland).
Upcoming
Asian High throughput screening Asian High throughput screening
The Asian High Throughput Screening market was valued at $2547.3 million in 2013 and is expected to reach $3931.2 million by 2018, growing at a CAGR of 9.1% from 2013 to 2018. High Throughput Screening market is primarily categorized by technology, product, end user, and application. By technology, the HTS market is categorized into ultra high throughput screening (uHTS), cell-based assays, lab-on-a-chip, label-free technology, and bioinformatics. By product, the HTS market is segmented into instruments, consumables/reagents, and software and services. By end user, the High Throughput Screening market is categorized into pharmaceutical, biotechnology, academia and government, contract research organizations, and others. By application, the High Throughput Screening market is classified into target identification, primary screening, toxicology, stem cell biology, and others. Major players in the market include Agilent Technologies, Inc. (U.S.), PerkinElmer (U.S.), Beckman Coulter, Inc. (a subsidiary of Danaher Corporation) (U.S.), Sigma-Aldrich Corporation (U.S.) and Tecan Group (Switzerland).
Upcoming
3 of 3 items
3 reports | Show
Connect With Us
US/CAN : +1-888-502-0539